Concepedia

Publication | Open Access

Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes

DOIFull Paper Access

103

Citations

17

References

2017

Year

Seigo Sugiyama, Hideaki Jinnouchi, Noboru Kurinami, Kunio Hieshima, Akira Yoshida, Katsunori Jinnouchi, Hiroyuki Nishimura, Tomoko Suzuki, Fumio Miyamoto, Keizo Kajiwara,
Journal of Atherosclerosis and Thrombosis

Abstract

Treatment with dapagliflozin for six months significantly improved glycemic control and reduced body weight without reducing muscle mass in T2DM patients.

References

YearCitations

Page 1